Newsroom
Independent Review into Mental Health Conditions, ADHD and Autism – Interim Report
The UK Department of Health and Social Care published an interim report examining trends in ADHD, autism and broader mental health conditions. The report highlights limitations in structured electronic health record data, noting that under‑recording and incomplete coding can miss clinically relevant detail. Drawing on analysis using Akrivia Health data, the report underscores the importance of incorporating insights from free‑text clinical notes, particularly for identifying complex and co‑occurring conditions and better understanding real‑world care pathways.
March 2026
GlobalMinds – National Coverage
GlobalMinds has received national coverage, highlighting the scale and ambition of the study. Led by Akrivia Health, the study is advancing more personalised approaches to research in severe mental illness, with close to 2,000 participants recruited across England. This reflects ongoing collaboration across NHS sites, research partners, third sector organisations, and continued progress in delivering the study.
February 2026
GlobalMinds and NHS DigiTrials
GlobalMinds, sponsored and delivered by Akrivia Health, is working with NHS DigiTrials to support the identification and invitation of potential participants to the study. NHS DigiTrials enables large‑scale, data‑driven recruitment by using national health data to reach individuals who may be eligible to take part in research. This approach supports efficient study recruitment and helps broaden access to participation across NHS populations.
February 2026
GlobalMinds – Featured in The Independent
GlobalMinds has been featured in The Independent, highlighting the scale and ambition of the study. Led by Akrivia Health, the study continues to progress with close to 2,000 participants recruited across England, reflecting ongoing delivery across multiple NHS sites.
February 2026
GlobalMinds and Rethink Mental Illness
GlobalMinds, sponsored and delivered by Akrivia Health, is working in partnership with Rethink Mental Illness in relation to engagement activity associated with the study. GlobalMinds is a mental health research study focused on using real‑world data from NHS records to support research into conditions such as schizophrenia, dementia, and other serious mental illnesses.
2025
- Wellcome London
Akrivia Network Strategy Day
Akrivia Health hosted a strategic gathering of partners from healthcare and research to align on the future direction of the Akrivia Network, focusing on collaboration, data-driven research, and shared priorities in mental health and neuroscience.
8th July 2025
- Oxford
SMARTbiomed Workshop
Akrivia Health hosted a two-day hands-on workshop with SMARTbiomed (a collaboration between the University of Oxford and Denmark) to help researchers get to grips with our dataset. The sessions walked participants through how to use longitudinal psychiatric EHR data effectively — and showed just how much research potential the Akrivia dataset holds. The workshop was facilitated by Panagiota Kontari, Benjamin Fell, Sophie Turner, Gloria Roque, Maxime Taquet, Dr William Pettersson-Yeo, Dalila Monica Moisescu, Clara Lewis, and Marcus Sefranek, in collaboration with Naomi Wray from the Pioneer Centre for SMARTbiomed.
June 2025
- Liverpool
BNA 2025
Akrivia Health joined the British Neuroscience Association Festival 2025, engaging with students, researchers, and clinicians. Tanisha and Laura staffed the booth, while Ana Todorovic and Dalila Monica Moisescu presented posters on mental health data and dementia risk. A symposium featured Benjamin Fell, Shaun Rowark, and Dr. William Pettersson-Yeo discussing how NLP-enriched health records can improve schizophrenia treatment guidelines. Akrivia also sponsored the Career Zone, supporting neuroscience research and mental health progress.
27th – 30th April
- Wales
RCPsych 2025
Akrivia Health was at the 2025 RCPsych Congress in Wales, connecting with psychiatrists and organisations working to move mental health forward. Conversations throughout the event reinforced how important better data is in tackling the field’s toughest challenges — exactly where Akrivia fits in. Representing Akrivia were David Newton, Benjamin Fell, Georgina Ireland, Laura Akonor and Tanisha Kamat.
23rd – 26th June
- Manchester
RDF 2025
Akrivia Health took part in the 2025 Research and Development Forum, connecting with researchers and partners from across the UK around improving how mental health research is delivered. Representing Akrivia were David Price, Theana Hickman, Lauren H., and Tanisha Kamat, who kept conversations going at the stand throughout the event.
18th – 20th May
- Vienna
AD/PD 2025
At AD/PD 2025 in Vienna, Akrivia Health joined global conversations on neurodegenerative disease research. Panagiota Kontari presented a well-received poster on depression treatments and dementia risk using real-world mental health data. Georgina Ireland also represented Akrivia, engaging with the scientific community. The event highlighted collaboration across clinical science, neuroscience, and industry.
1st – 5th April 2025
BAP 2025
Dr William Pettersson-Yeo, presented research at the BAP 2025 summer meeting. His study developed and validated a tool using data from 10 NHS Trusts to predict treatment-resistant schizophrenia earlier. This aimed to enable more personalized and timely care for patients. The research demonstrated the value of real-world data in driving collaboration and impactful healthcare solutions.
July 2025
- Chicago
SIRS 2025
At SIRS 2025 in Chicago, Akrivia Health was represented by David Newton and Ceyda Uysal. The event focused on advancing understanding and treatment of schizophrenia. Key discussions highlighted how real-world evidence can accelerate innovation in mental health care. The event provided valuable networking with researchers and industry leaders committed to improving schizophrenia outcomes.